These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. Hill ME; Shiono H; Newsom-Davis J; Willcox N J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675 [TBL] [Abstract][Full Text] [Related]
43. Human intestinal development in a severe-combined immunodeficient xenograft model. Savidge TC; Morey AL; Ferguson DJ; Fleming KA; Shmakov AN; Phillips AD Differentiation; 1995 Jun; 58(5):361-71. PubMed ID: 7622011 [TBL] [Abstract][Full Text] [Related]
44. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. Graus YF; de Baets MH; Parren PW; Berrih-Aknin S; Wokke J; van Breda Vriesman PJ; Burton DR J Immunol; 1997 Feb; 158(4):1919-29. PubMed ID: 9029134 [TBL] [Abstract][Full Text] [Related]
45. Adult human autoimmune thymus transplantation into nude mice - functioning of human thymus epithelium in nude mice. Tsuchiya M; Shimabukuro K; Mizuno Y; Yoshida T; Ono A; Yoshimatsu H Biochem Exp Biol; 1978; 14(2):101-6. PubMed ID: 753369 [TBL] [Abstract][Full Text] [Related]
46. Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis. Cavalcante P; Barberis M; Cannone M; Baggi F; Antozzi C; Maggi L; Cornelio F; Barbi M; Didò P; Berrih-Aknin S; Mantegazza R; Bernasconi P Neurology; 2010 Apr; 74(14):1118-26. PubMed ID: 20368632 [TBL] [Abstract][Full Text] [Related]
47. The thymus in myasthenia gravis. Hohlfeld R; Wekerle H Neurol Clin; 1994 May; 12(2):331-42. PubMed ID: 8041345 [TBL] [Abstract][Full Text] [Related]
48. Influence of human myasthenia gravis thymus on the differentiation of human cord blood stem cells in SCID mice. Li QR; Liu PP; Xuan XY; Guan SS; Du Y; Gao F; Zhang QY Neurol Sci; 2014 Feb; 35(2):191-7. PubMed ID: 23807119 [TBL] [Abstract][Full Text] [Related]
49. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis: identification of regulatory cells. Shi FD; Li H; Wang H; Bai X; van der Meide PH; Link H; Ljunggren HG J Immunol; 1999 May; 162(10):5757-63. PubMed ID: 10229808 [TBL] [Abstract][Full Text] [Related]
51. Thymic seminoma and myasthenia gravis. Williams IM; Gee DC; Cooper E; Dickinson P; Sandeman TF; Sum AC J Clin Neuroophthalmol; 1985 Dec; 5(4):254-7. PubMed ID: 2934429 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma. Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295 [TBL] [Abstract][Full Text] [Related]
53. Establishment of a human thymic myoid cell line. Phenotypic and functional characteristics. Wakkach A; Poea S; Chastre E; Gespach C; Lecerf F; De La Porte S; Tzartos S; Coulombe A; Berrih-Aknin S Am J Pathol; 1999 Oct; 155(4):1229-40. PubMed ID: 10514405 [TBL] [Abstract][Full Text] [Related]
54. Antibodies against myoid thymic cells and striated muscle, and monoclonal gammapathy in myasthenia gravis. Faure A; Gattegno L; Modigliani E; Sebaoun J; Eyquem A; Cornillot P Biomedicine; 1975 Jun; 23(6):241-5. PubMed ID: 813790 [TBL] [Abstract][Full Text] [Related]
55. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation. Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516 [TBL] [Abstract][Full Text] [Related]
56. The thymus and myasthenia gravis: immunological and neurophysiological aspects. Carrieri PB; Marano E; Perretti A; Caruso G Ann Med; 1999 Oct; 31 Suppl 2():52-6. PubMed ID: 10574156 [TBL] [Abstract][Full Text] [Related]
57. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. Melms A; Schalke BC; Kirchner T; Müller-Hermelink HK; Albert E; Wekerle H J Clin Invest; 1988 Mar; 81(3):902-8. PubMed ID: 2449461 [TBL] [Abstract][Full Text] [Related]
58. Immunologic aspects of myasthenia gravis. Lisak RP Ann Clin Lab Sci; 1975; 5(4):288-93. PubMed ID: 1099979 [TBL] [Abstract][Full Text] [Related]
59. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Kirchner T; Schalke B; Melms A; von Kügelgen T; Müller-Hermelink HK Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):237-57. PubMed ID: 2879380 [TBL] [Abstract][Full Text] [Related]
60. Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia. Matsui N; Ohigashi I; Tanaka K; Sakata M; Furukawa T; Nakagawa Y; Kondo K; Kitagawa T; Yamashita S; Nomura Y; Takahama Y; Kaji R J Neuroimmunol; 2014 Apr; 269(1-2):56-61. PubMed ID: 24556356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]